End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.52 EGP | 0.00% | 0.00% | -4.22% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 503.9 | 507.6 | 703.1 | 949.2 | 1,121 | 1,498 |
Enterprise Value (EV) 1 | 418.7 | 376.6 | 547.4 | 735.1 | 891.2 | 1,257 |
P/E ratio | 12.4 x | 8.86 x | 16.1 x | 15.1 x | 17.6 x | 16.4 x |
Yield | - | - | - | 0.56% | - | - |
Capitalization / Revenue | 2.66 x | 2.36 x | 3.24 x | 3.79 x | 3.79 x | 4.13 x |
EV / Revenue | 2.21 x | 1.75 x | 2.52 x | 2.93 x | 3.01 x | 3.47 x |
EV / EBITDA | 7.7 x | 5.2 x | 9.26 x | 9.39 x | 13.2 x | 14.1 x |
EV / FCF | 16.4 x | 10.8 x | 26.4 x | 15.4 x | 1,104 x | -53.6 x |
FCF Yield | 6.11% | 9.29% | 3.8% | 6.49% | 0.09% | -1.86% |
Price to Book | 2.74 x | 2.16 x | 2.57 x | 2.9 x | 2.95 x | 3.22 x |
Nbr of stocks (in thousands) | 220,003 | 220,003 | 220,003 | 220,003 | 220,003 | 220,000 |
Reference price 2 | 2.291 | 2.307 | 3.196 | 4.315 | 5.094 | 6.808 |
Announcement Date | 2/5/19 | 2/2/20 | 2/8/21 | 2/3/22 | 2/9/23 | 2/15/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 189.7 | 214.9 | 217 | 250.5 | 295.8 | 362.3 |
EBITDA 1 | 54.38 | 72.46 | 59.09 | 78.29 | 67.61 | 89.33 |
EBIT 1 | 48.12 | 65.75 | 52.49 | 72.1 | 61.42 | 81.65 |
Operating Margin | 25.36% | 30.6% | 24.19% | 28.78% | 20.76% | 22.54% |
Earnings before Tax (EBT) 1 | 56.28 | 78.76 | 64.84 | 86.22 | 85.1 | 122.1 |
Net income 1 | 43.13 | 60.5 | 49.6 | 65.88 | 63.52 | 91.51 |
Net margin | 22.73% | 28.16% | 22.86% | 26.3% | 21.47% | 25.26% |
EPS 2 | 0.1854 | 0.2604 | 0.1988 | 0.2849 | 0.2887 | 0.4160 |
Free Cash Flow 1 | 25.56 | 35 | 20.77 | 47.71 | 0.8075 | -23.44 |
FCF margin | 13.48% | 16.29% | 9.57% | 19.05% | 0.27% | -6.47% |
FCF Conversion (EBITDA) | 47.01% | 48.3% | 35.15% | 60.93% | 1.19% | - |
FCF Conversion (Net income) | 59.27% | 57.84% | 41.88% | 72.41% | 1.27% | - |
Dividend per Share | - | - | - | 0.0240 | - | - |
Announcement Date | 2/5/19 | 2/2/20 | 2/8/21 | 2/3/22 | 2/9/23 | 2/15/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 85.2 | 131 | 156 | 214 | 229 | 241 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 25.6 | 35 | 20.8 | 47.7 | 0.81 | -23.4 |
ROE (net income / shareholders' equity) | 26% | 28.9% | 19.5% | 21.9% | 18% | 21.7% |
ROA (Net income/ Total Assets) | 14.4% | 16% | 10.7% | 12.7% | 9.35% | 10.4% |
Assets 1 | 299.1 | 378.4 | 464.5 | 520.3 | 679.7 | 877.2 |
Book Value Per Share 2 | 0.8300 | 1.070 | 1.240 | 1.490 | 1.730 | 2.110 |
Cash Flow per Share 2 | 0.3900 | 0.6000 | 0.7100 | 0.9800 | 0.5400 | 0.3500 |
Capex 1 | 11.5 | 10 | 11.1 | 12.2 | 30.6 | 90.6 |
Capex / Sales | 6.04% | 4.66% | 5.13% | 4.87% | 10.35% | 25% |
Announcement Date | 2/5/19 | 2/2/20 | 2/8/21 | 2/3/22 | 2/9/23 | 2/15/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-4.22% | 29.91M | |
-33.38% | 13.43B | |
+5.31% | 11.95B | |
-4.50% | 11.66B | |
+13.14% | 11.08B | |
+30.61% | 8.61B | |
+24.64% | 7.63B | |
+8.05% | 6.45B | |
+16.63% | 4.39B | |
-7.45% | 4.11B |
- Stock Market
- Equities
- NINH Stock
- Financials Nozha International Hospital